8158 — China Regenerative Medicine International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
HK$121.70m
Enterprise Value
HK$152.69m
Revenue
HK$90.62m

Annual balance sheet for China Regenerative Medicine International, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4.77	9.93	1.85	3.33	22.7
Net Total Accounts Receivable
Net Total Receivables	117	197	238	158	0.622
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	144	258	249	169	58.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.3	0.753	26.8	17.3	6.99
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	152	259	276	186	136
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	201	147	158	148	58.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	94.4	147	172	174	111
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	58.1	112	104	11.8	25.2
Total Liabilities & Shareholders' Equity	152	259	276	186	136
Total Common Shares Outstanding